LOBE Share Price Performance
CA$0.05
0.04 (233.33%)
Price CA$0.05
Share PriceCA$0.05
Lobe Sciences Ltd. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
LOBE Community Narratives
There are no narratives available yet.
Recent LOBE News & Updates
Lobe Sciences Ltd. Key Details
Last Reported Earnings
May 31, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.02
- Gross Margin
- 0%
- Net Profit Margin
- 0%
- Debt/Equity Ratio
- 73.0%
Lobe Sciences Ltd. Competitors
Snowflake Analysis
About LOBE
- Founded
- 2018
- Employees
- n/a
- CEO
- WebsiteView website
Lobe Sciences Ltd., a biopharmaceutical company, engages in the research and development using sub-hallucinatory doses of proprietary psychedelic compounds to improve brain and mental health, and wellness in Canada. The company was formerly known as Greenstar Biosciences Corp. and changed its name to Lobe Sciences Ltd. in November 2020. Lobe Sciences Ltd. was founded in 2018 and is headquartered in Vancouver, Canada.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
Canadian Market Performance
- 7 Days: 1.3%
- 3 Months: 10.9%
- 1 Year: 22.4%
- Year to Date: 20.2%
The market has climbed by 1.3% over the past week, with every sector up and the Materials sector leading the way. In the last year, the market has climbed 22%. Looking forward, earnings are forecast to grow by 11% annually. Market details ›